ARM MED LTD
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-06-30 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 address
- • 1 confirmation-statement
- • 1 address
Corporate timeline (5 events)Click to expand
- 2026-06-20📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-12-24📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-06-17🏢Company incorporatedAs ARM MED LTD
- 2024-06-17➕IQBAL, Ayesha appointeddirector
- 2024-06-17📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 2.1 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Ms Ayesha Iqbal Individual · Pakistani · DOB 11/1980 · age 46 | 50–75% | 50–75% | board control50-75% shares · 50-75% voting · board control | 17/06/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · CV postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ADROIT GIDEON MEDICAL LTD→ 14004742 · est 2022 | — | — | £1.0k | — | 4y | — | — |
| AKFEM VENTURE LIMITED→ 16611271 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ALCHEMY MEDICORUM LIMITED→ 10962122 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ALFAMED SPECIALIST EMERGENCY CARE LTD→ 15100221 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ALLIANCE DIAGNOSTIC SERVICES LIMITED→ 04026369 · est 2000 · no financials extracted | — | — | — | — | 25y | — | — |
| ALLOW US CARE LTD→ 16236739 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ALLYFAZY HEALTHCARE SERVICES LTD→ 13156342 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ALMOND CARE CHILDRENS SERVICES LIMITED→ 11736763 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ALMOND CARE LIMITED→ 07033238 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| ALTA MEDICA LIMITED→ 15620213 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ALVINE LTD→ 15929586 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALWAR (INTERNATIONAL) LIMITED→ 08196795 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.